These General Terms and Conditions ("AGB") govern the access to and use of the website neuroprecision-engine.com (the "Website") and any non-binding pre-incorporation communication with the operators. They are based on Swiss law, in particular the Swiss Code of Obligations (CO / OR, SR 220) and the Swiss Civil Code (ZGB, SR 210).
1. Operator and contracting party
The Website is operated jointly and personally by Suvija Münow-Suthakaran and Tahnee Jessica Münow as natural persons in Sursee, Canton Lucerne, Switzerland. NeuroPrecision-Engine is a pre-incorporation venture and is not yet registered as a legal entity (Art. 530 et seq. CO concerning a simple partnership applies between the two natural persons; no commercial register entry exists). All contractual statements and any future binding offers therefore originate from the two natural persons themselves and not from a corporate body.
2. Scope
These AGB apply to every visitor and user of the Website. By accessing the Website you accept these terms in the version available at the time of your visit. The operators may amend these AGB at any time; the version applicable to a given visit is the version published on this page on the date of that visit.
3. Nature of the content
All content on the Website (including, without limitation, descriptions of the 65-gate pipeline, statistical figures, disease catalogue, in-silico results, illustrations and screenshots) is provided for general information and demonstration purposes only. It is not a medical, scientific, regulatory, legal, financial or investment recommendation, and it does not replace independent professional advice. The Website does not constitute a binding offer (Art. 7 CO).
4. No warranty / accuracy
The operators take reasonable care in compiling and presenting the information on the Website, but make no warranty as to its accuracy, completeness, timeliness, fitness for a particular purpose, or non-infringement of third-party rights. In particular, computational results displayed on this Website are illustrative; running the actual pipeline on a given target or indication is required to obtain a binding scientific result.
5. Limitation of liability
To the fullest extent permitted by mandatory Swiss law (Art. 100 and Art. 101 CO), the operators exclude any liability for direct, indirect, incidental or consequential damages arising from access to or use of the Website, from reliance on its content, or from temporary unavailability or technical failure of the Website. Liability for unlawful intent or gross negligence remains reserved as required by Art. 100(1) CO.
6. External links
The Website may contain links to third-party websites (e.g. UniProt, ChEMBL, ClinicalTrials.gov, AlphaFold-DB, NVIDIA NIM endpoints). The operators have no influence on the content, availability or data-protection practices of those third parties and accept no liability for their content. Following such links is at the visitor's own responsibility.
7. Intellectual property
All content on the Website — including text, design elements, the NPE logo, source code, illustrations, screenshots, the 65-gate pipeline architecture and the 791-disease catalogue — is the intellectual property of the operators or used with permission of the respective rights holders. Reproduction, distribution, public display, modification, reverse engineering or commercial use, in whole or in part, requires the prior written consent of the operators (Art. 9 ff. of the Swiss Copyright Act, URG, SR 231.1; Arts. 28 and 29 ZGB regarding personality rights).
8. Trademarks and naming
"NeuroPrecision-Engine", "NPE" and the NPE wordmark are used by the operators as commercial designations within the meaning of Art. 1 of the Swiss Trademark Act (MSchG, SR 232.11). Use by third parties without prior written consent is not permitted.
9. User obligations
Visitors and users undertake (a) not to attempt unauthorised access to non-public parts of the Website, (b) not to use the Website for any unlawful purpose or in a manner liable to damage the Website, the operators or third parties, (c) not to scrape, harvest or republish substantial parts of the disease catalogue or pipeline data without prior written consent, and (d) to refrain from any conduct contrary to public order or accepted morality (Art. 19 and Art. 20 CO).
10. Data protection
The processing of personal data on this Website is governed by our Privacy Policy and complies with the Swiss Federal Act on Data Protection (FADP / nFADP, SR 235.1) and, where applicable, the EU General Data Protection Regulation (GDPR, Reg. (EU) 2016/679). See the Privacy Policy for details.
11. Severability
Should individual provisions of these AGB be or become invalid, void or unenforceable, the remaining provisions shall remain in full force and effect. The invalid provision shall be replaced by a valid provision that most closely matches the economic intent of the original provision, in accordance with Art. 20(2) CO.
12. Governing law and jurisdiction
These AGB and any non-contractual obligations arising from or in connection with the Website are governed exclusively by Swiss substantive law, with the express exclusion of conflict-of-laws rules and the United Nations Convention on Contracts for the International Sale of Goods (CISG). Sole place of jurisdiction is the competent court in Sursee, Canton Lucerne, Switzerland — subject to any mandatory consumer-protection forum a visitor may have under their Swiss or EU domicile law (Art. 32 of the Swiss Code of Civil Procedure, ZPO, SR 272; Art. 114 PILA, SR 291).
Version 1.0 — published February 2026, Sursee, Switzerland.
